+ All Categories
Home > Documents > Pharmacology in the Lifecycle

Pharmacology in the Lifecycle

Date post: 25-Feb-2016
Category:
Upload: donagh
View: 38 times
Download: 0 times
Share this document with a friend
Description:
Pharmacology in the Lifecycle. Mike Ori. Compare fat, muscle, body water, renal clearance, hepatic clearance, and skin qualities across the lifecycle. Comparisons to adult. Discuss the various methods of drug delivery across the lifecycle. - PowerPoint PPT Presentation
Popular Tags:
22
Pharmacology in the Lifecycle Mike Ori
Transcript
Page 1: Pharmacology in the Lifecycle

Pharmacology in the Lifecycle

Mike Ori

Page 2: Pharmacology in the Lifecycle

• Compare fat, muscle, body water, renal clearance, hepatic clearance, and skin qualities across the lifecycle

Page 3: Pharmacology in the Lifecycle

Age Fat Muscle Water Renal Hepatic SkinPremie Very low Low Very High Very low Very low Thinner

HyperperfusedIncreased surface area

Neonate Low Low High Very low Very low ThinnerHyperperfusedIncreased surface area

Infant High Low Normal Normal Very high

Child Low Normal Normal High High

Adolescent Low Normal Normal Normal High

Adult Normal Normal Normal Normal Normal Normal

Elder Adult High Low Low Low Low \/ lipid, thin

Comparisons to adult

Page 4: Pharmacology in the Lifecycle
Page 5: Pharmacology in the Lifecycle
Page 6: Pharmacology in the Lifecycle
Page 7: Pharmacology in the Lifecycle

• Discuss the various methods of drug delivery across the lifecycle

Page 8: Pharmacology in the Lifecycle

Age IM Transdermal

Rectal Oral - pills Soft/liquid

IV

Premie No Caution Variable No Liquid YesNeonate No Caution Variable No Liquid YesInfant ? Caution ? No Yes YesChild ? ? ? > 6 yo Yes YesAdolescent Yes Yes Yes Yes Yes YesAdult Yes Yes Yes Yes Yes YesElder Adult No Caution Yes Swallowin

g?Yes Yes

Page 9: Pharmacology in the Lifecycle

• Explain why off-label use of pharmaceuticals is high in pediatrics

Page 10: Pharmacology in the Lifecycle

• Safety and efficacy studies are typically carried out in healthy young adults therefore evidence based dosing regimens are not available for children. Case studies, expert opinion, and other less rigorous methodologies are commonly relied on.

Page 11: Pharmacology in the Lifecycle

• Discuss in general terms the pediatric applicability of cockroft-gault, traub-johnson, and the schwartz equation

Page 12: Pharmacology in the Lifecycle

• Cockroft-gault is for use in adults age 18 and older.

• Schwartz and traub-johnson are both suitable for use in pediatrics

Page 13: Pharmacology in the Lifecycle

• Describe the status of the blood brain barrier in geriatric patients and relate this to the beers list

Page 14: Pharmacology in the Lifecycle

• The BBB is not as tight in geriatric patients which results in increase CNS effects of drugs targeted to the CNS and to drugs with CNS side effect.

Page 15: Pharmacology in the Lifecycle

• Describe the importance of the Beer list in geriatric patients

Page 16: Pharmacology in the Lifecycle

• Because of diminished eyesight and cognition changes, many geriatric patients prefer choosing beers from a picture list.

• Alternatively, it’s a list of drugs, created by consensus of expert opinion, that should be avoided or used with caution in older adults.

Page 17: Pharmacology in the Lifecycle

• Describe the hydration status of geriatric patients

Page 18: Pharmacology in the Lifecycle

• They have lower total body water, impaired baroreceptors, impaired renal concentration capability all of which combined with social factors to limit hydration. As a result, many geriatric patients are hypovolemic, hyponatremic, and hyperkalemic.

Page 19: Pharmacology in the Lifecycle

• What are the risk factors for elder abuse?

Page 20: Pharmacology in the Lifecycle

• Cognitively impaired, dependent female living alone

• Vulnerable adult living with others, physically or financially dependent

• Family history of domestic abuse• Caregiver with mental illness or substance abuse• Caregiver forced by circumstance to care for the

elder

Page 21: Pharmacology in the Lifecycle

• What are potential signs of elder abuse

Page 22: Pharmacology in the Lifecycle

• Prolonged interval between trauma or illness and presentation

• Suspicious hx of unexplained injuries• Irregular follow-up, lack of adherence• Elder not given opportunity to speak for

themselves• Vulnerable adult: Fearful or withdrawn behavior• Caregiver: indifferent or angry


Recommended